feed,title,long_url,short_url
Benzinga,Longeveron's Allogeneic Cell Therapy Completes Early-Stage Study In Congenital Heart Defect,https://benzinga.com/general/biotech/21/02/19832103/longeverons-allogeneic-cell-therapy-completes-early-stage-study-in-congenital-heart-defect,
